Answers are grounded in this paper and cite their sources.
We present a young boy with a diagnosis of homozygous familial hypercholesterolemia who presented with statin and ezetimibe resistance. The patient received lipoprotein apheresis at 6 years of age. His low-density lipoprotein cholesterol levels significantly were reduced by adding lomitapide and evinacumab, and his carotid plaque started to regress.
No takes yet. Share an insight, caveat, or question.
Tada et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: